Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Agreement: Food DetectiveT in India

26 Nov 2010 07:00

RNS Number : 8411W
Omega Diagnostics Group PLC
26 November 2010
 



 

Omega Diagnostics Group PLC

("Omega")

Distribution Agreement for Food Detective™ in India

 

Omega, a leading producer of diagnostic testing kits for Food Intolerance announces that its subsidiary, Cambridge Nutritional Sciences Limited, has signed an exclusive distribution agreement with existing marketing partner Thermo Fisher Scientific India Pvt. Ltd. (TFSI) covering the sale and distribution of its Food Detective™ product into the Indian market. The product has recently been approved by the Indian authorities therefore marketing and sale of the product will commence immediately.

 

Mr Andrew Shepherd, CEO of Omega, said: "We're very pleased to announce this deal with TFSI for distribution of Food Detective™ in India which expands our successful business relationship in this strategic market for the company. The product is now being used in over 50 countries and sales for the six months ending 30 September 2010 were £369,000. The Indian Agreement is expected to lead to additional sales of approximately £300,000 over the next three years. This product is well accepted as being a reliable test for those people suffering from the effects of food intolerance. This cost effective test has great potential in the Indian market which will provide a rapid means for more people to realise if their chronic symptoms are food related."

 

Commenting on the distribution agreement, Mr Girish Mehta, Director of TFSI said: "Food Detective™ is a unique product which will address the long unmet demand of identifying food intolerance amongst Indians. This product has been customised for the Indian food diet and has been priced affordably to reach a large population. Thermo Fisher Scientific India with its well-trained and experienced technical and sales teams is well positioned to market Food Detective™ in India and we hope that it will be a big success."

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

 

paul.mcmanus@walbrookpr.com

Paul Cornelius

Tel: 020 7933 8794

 

Mob: 07866 384 707

 

paul.cornelius@walbrookir.com

 

 

 

Information on Omega Diagnostics Group PLC:

Omega sells 86% of production (by turnover) through a network of distributors in over 100 countries. The largest distributor by sales value in the year ending 31 March 2010 was TFSI accounting for approximately 8% of Omega's sales in that financial year.

 

Information on Thermo Fisher Scientific India Pvt. Ltd. /Thermo Fisher Scientific (TFS):

Thermo Fisher Scientific India (TFSI) is the wholly owned subsidiary of Thermo Fisher Scientific USA (TFS) and is a USD 150 million sales organization. TFS is the world wide leader in serving science and offers one-stop-shop solutions to scientific laboratories associated with research, academia, industry, diagnostic testing, quality control, quality assurance etc. TFSI employs over 650 highly qualified and trained personnel to serve the needs of the Indian market and currently offers a wide range of products ranging from state-of-the-art scientific instruments to the smallest of laboratory consumables.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPGGMUGUPUGMA
Date   Source Headline
16th Sep 202211:13 amRNSPurchase of Shares by Directors
13th Sep 20227:00 amRNSInvestor presentation and Confirmation of AGM
12th Sep 20227:00 amRNSFinal Results
2nd Sep 202210:15 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSChange of preliminary results date
12th Aug 20227:00 amRNSChange of preliminary results date
8th Aug 20227:00 amRNSConfirmation of Preliminary Results
5th Aug 202212:09 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSCompletion of Sale of the CD4 Business
11th Jul 20227:00 amRNSPayment received
4th Jul 20227:00 amRNSHeads of Terms agreed for Sale of CD4 Business
23rd Jun 20223:13 pmRNSHolding(s) in Company
10th Jun 20227:00 amRNSGrant of share incentive awards
8th Jun 20221:47 pmRNSPDMR/Director Dealing
6th Jun 20222:29 pmRNSResult of General Meeting and Total Voting Rights
1st Jun 20227:00 amRNSResult of Open Offer
13th May 202210:05 amRNSPosting of Circular and Notice of General Meeting
11th May 20223:28 pmRNSHolding(s) in Company
6th May 20227:01 amRNSInvestor presentation
6th May 20227:00 amRNSPlacing, Subscription and Open Offer
7th Apr 20227:00 amRNSTrading Update
11th Mar 20227:00 amRNSUpdate on validation under CTDA legislation
8th Mar 20224:41 pmRNSSecond Price Monitoring Extn
8th Mar 20224:36 pmRNSPrice Monitoring Extension
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
7th Mar 20223:40 pmRNSResult of General Meeting
7th Mar 202211:03 amRNSConfirmation of Sale of Alva business
1st Mar 20227:00 amRNSResult of Open Offer
18th Feb 20227:00 amRNSInvestor Meeting
14th Feb 20222:06 pmRNSSecond Price Monitoring Extn
14th Feb 20222:01 pmRNSPrice Monitoring Extension
11th Feb 202211:05 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension
11th Feb 20227:01 amRNSFundraising to raise gross proceeds of up to £7m
11th Feb 20227:00 amRNSSale of Alva manufacturing business
10th Feb 20222:06 pmRNSSecond Price Monitoring Extn
10th Feb 20222:00 pmRNSPrice Monitoring Extension
10th Feb 20221:33 pmRNSSpeculation regarding a potential fundraise
8th Feb 20224:41 pmRNSSecond Price Monitoring Extn
8th Feb 20224:36 pmRNSPrice Monitoring Extension
3rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20224:36 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSCE-Mark for self-test for VISITECT® COVID-19 test
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSpeculation regarding a potential fundraise
19th Jan 20227:00 amRNSDirectorate Change
10th Jan 20223:20 pmRNSConfirmation of detection of Omicron variant
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.